Pituitary suppression in ultrasound-monitored frozen embryo replacement cycles. A randomised study

Human Reproduction

Volumn 19, Issue 4, 2004, Pages 874-879

  El Toukhy, Tarekel ^a   Taylor, A ^a,b   Khalaf, Y ^a   Al Darazi, K ^a   Rowell, P ^a   Seed, P ^a,b   Braude, P ^a,b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cryo thawed cycle outcome; Embryo cryopreservation; Pituitary suppresion

Indexed keywords

BUSERELIN; BUSERELIN ACETATE; ESTRADIOL VALERATE; FOLLITROPIN; GONADORELIN AGONIST; PROGESTERONE;

ADULT; ARTICLE; BIRTH RATE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOPRESERVATION; EMBRYO TRANSFER; ENDOMETRIUM; FEMALE; FERTILIZATION; FOLLITROPIN BLOOD LEVEL; HUMAN; HYPOPHYSIS FUNCTION; MAJOR CLINICAL STUDY; OVULATION; PREGNANCY RATE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; ULTRASOUND;

EID: 1842584998     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh183     Document Type: Article

References (43)

1. Al-Shawaf T, Yang D, Al-Magid Y and Craft I (1993) Ultrasonic monitoring during replacement of frozen/thawed embryos in natural and hormone replacement cycles. Hum Reprod 8,2068-2074.
2. Bergh PA and Navot D (1992) The impact of embryonic development and endometrial maturity on the timing of implantation. Fertil Steril 58,537-542.
3. Buffet N and Bouchard P (2001) The neuroendocrine regulation of the human ovarian cycle. Chronobiol Int 18,893-919.
4. Cohen J, De Vane GW, Elsner CW, Kort HI, Massey JB and Norbury SE (1998) Cryopreserved zygotes and embryos and endocrinologic factors in the replacement cycle. Fertil Steril 50,61-67.
5. Cook R and Sackett D (1995) The number needed to treat: A clinically useful measure of treatment effect. BMJ 310,452-454.
6. Dal Prato L, Borini A, Cattoli M, Bonu MA, Sciajno R and Flamigni C (2002) Endometrial preparation for frozen-thawed embryo transfer with or without pretreatment with gonadotropin-releasing hormone agonist. Fertil Steril 77, 956-960.
7. Daya S (2003) Intention-to-treat analysis: A necessity for clinical trials. Evidence-based Obstet Gynecol 5,1-3.
8. de Ziegler D, Cornel C, Bergeron C, Hazout A, Bouchard P and Frydman R (1991) Controlled preparation of the endometrium with exogenous estradiol and progesterone in women having functioning ovaries. Fertil Steril 56,851-855.
9. Edgar DH, Bourne H, Speirs AL and McBain JC (2000) A quantitative analysis of the impact of cryopreservation on the implantation potential of human early cleavage stage embryos. Hum Reprod 15,175-179.
10. Elomaa K and Lahteenmaki P (1999) Ovulatory potential of preovulatory sized follicles during oral contraceptive treatment. Contraception 60,275-279.
11. Gebbie AE, Glasier A and Sweeting V (1995) Incidence of ovulation in perimenopausal women before and during hormone replacement therapy. Contraception 52,221-222.
12. Gerris J, De Neubourg D, Mangelschots K, Van Royen E, Van de Meerssche M and Valkenburg M (1999) Prevention of twin pregnancy after in-vitro fertilization or intracytoplasmic sperm injection based on strict embryo criteria: A prospective randomized clinical trial. Hum Reprod 14,2581-2587.
13. Guidice LC (1994) Growth factors and growth modulators in human uterine endometrium: Their potential relevance to reproductive medicine. Fertil Steril 61,1-17.
14. Han SW, Lei ZM and Rao CV (1999) Treatment of human endometrial stromal cells with chorionic gonadotropin promotes their morphological and finctional differentiation into decidua. Mol Cell Endocrinol 147,7-16.
15. Ku SY, Choi YM, Suh CS, Kim SH, Kim JG, Moon SY and Lee YJ (2002) Effect of gonadotropins on human endometrial cell proliferation in vitro. Arch Gynecol Obstet 266,223-228.
16. Lassalle B, Testart J and Renard JP (1985) Human embryo features that influence the success of cryopreservation with the use of 12-propanediol. Fertil Steril 44,645-651.
17. Lelaidier C, de Ziegler D, Gaetano J, Hazout A, Fernandez H and Frydman R (1992) Controlled preparation of the endometrium with exogenous oestradiol and progesterone: A novel regimen not using a gonadotrophin-releasing hormone agonist Hum Reprod 7,1353-1356.
18. Licht P, Russu V and Wildt L (2001) On the role of human chorionic gonadotropin in the embryo-endometrial microenvironment: implications for differentiation and implantation. Semin Reprod Med 19,34-47.
19. Meldrum DR, Wisot A, Hamilton F, Gutlay-Yeo AL, Marr B and Hunyh D (1989) Artificial agonadism and hormone replacement for oocyte donation. Fertil Steril 52,509-511.
20. Muasher SJ, Kruithoff C, Simonetti S, Oehninger S, Acosta AA and Jones GS (1991) Controlled preparation of the endometrium with exogenous steroids for the transfer of frozen-thawed pre-embryos in patients with anovulatory or irregular cycles. Hum Reprod 6,443-445.
21. Oehninger S, Mayer J and Muasher S (2000) Impact of different clinical variables on pregnancy outcome following embryo cryopreservation. Mol Cell Endocrinol 169, 73-77.
22. Psychoyos A (1986) Uterine receptivity for nidation. Ann NY Acad Sci 476,36-42.
23. Queenan JT Jr, Ramey JW, Seltman H, Eure L, Veeck LL and Muasher SJ (1997) Transfer of cryo-preserved-thawed pre-embryos in a cycle using exogenous steroids without prior gonadotrophin-releasing hormone agonist suppression yields favourable pregnancy results. Hum Reprod 12, 1176-1180.
24. Queenan JT Jr, Veeck LL, Seltman H and Muasher SJ (1994) Transfer of cryo-preserved-thawed pre-embryos in a natural cycle or a programmed cycle with exogenous hormonal replacement yields similar pregnancy results. Fertil Steril 62,545-550.
25. Queenan JT Jr, Veeck LL and Muasher SJ (1995) Clinical and laboratory aspects of cryopreservation. Semin Reprod Endocrinol 13,64-71.
26. Remohi J, Vidal A and Pellicer A (1993) Oocyte donation in low responders to conventional ovarian stimulation for in-vitro fertilisation. Fertil Steril 59,1208-1215.
27. Reshef E, Lei ZM, Rao ChV, Pridham N, Chegini N and Luborsky JL (1989) The presence of gonadotropin receptors in non-pregnant human uterus human placenta fetal membranes and decidua. J Clin Endocrinol Metab 90,421-430.
28. Salat-Baroux JS, Cornet D, Alvarez S, Antoine JM, Tibi C, Mandelbaum J and Plachot M (1988) Pregnancies after replacement of frozen thawed embryos in a donation program. Fertil Steril 49,817-821.
29. Sathanandan M, Macnamee MC, Rainsbury P, Wick K, Brindson P and Edwards RG (1991) Replacement of frozen-thawed embryos in artificial and natural cycles: A prospective semi-randomised study. Hum Reprod 6,685-687.
30. Schmidt CL, de Ziegler D, Gagliardi CL, Mellon RW, Taney FH, Kuhar MJ, Colon JM and Weiss G (1989) Transfer of cryopreserved-thawed embryos: The natural cycle versus controlled preparation of the endometrium with gonadotropin-releasing hormone agonist and exogenous estradiol and progesterone (GEEP). Fertil Steril 52,609-616.
31. Sharkey A (1998) Cytokines and implantation. Rev Reprod 3,52-61.
32. Shemesh M (2001) Actions of gonadotrophins on the uterus. Reproduction 121,835-842.
33. Simon A, Hurwitz A, Zenter B, Bdolah Y and Laufer N (1998) Transfer of frozen-thawed embryos in artificially prepared cycles with and without prior gonadotrophin-releasing hormone agonist suppression: A prospective randomized study. Hum Reprod 13,2712-2717.
34. Simon A, Hurwitz A, Pharhat M, Revel A, Zentner B and Laufer N (1999) A flexible protocol for artificial preparation of the endometrium without prior gonadotropin-releasing hormone agonist suppression in women with functioning ovaries undergoing frozen-thawed embryo transfer cycles. Fertil Steril 71,609-613.
35. Speroff L, Glass RH and Kase NG (1994) Regulation of the menstrual cycle. In: Speroff L, Glass RH and KaseNG (eds) Clinical Gynecologic Endocrinology and Infertility 5th edition. Williams and Wilkins, Baltimore. pp 183-230.
36. Steer CV, Mills CL, Tan SL, Campbell S and Edwards RG (1992) The cumulative embryo score: A predictive embryo scoring technique to select the optimal number of embryos to transfer in an in-vitro fertilization and embryo transfer programme. Hum Reprod 7,117-119.
37. Sunder S and Lenton EA (2000) Endocrinology of the peri-implantation period. Baillieres Best Pract Res Clin Obstet Gynecol 14,789-800.
38. Testart J, Lefevre B and Cougeon A (1993) Effects of gonadotrophin-releasing hormone agonists (GnRHa) on follicle and oocyte quality. Hum Reprod 8,511-518.
39. Ubaldi F, Bourgain C, Tournaye H, Smitz J, Van Steirteghem A and Devroey P (1997) Endometrial evaluation by aspiration biopsy on the day of oocyte retrieval in the embryo transfer cycles in patients with serum progesterone rise during the follicular phase. Fertil Steril 67,521-526.
40. Van Royen E, Mangelschots K, De Neubourg D, Valkenburg M, Van der Meerssche M, Ryckaert G, Eestermans W and Gerris J (1999) Characterization of a top quality embryo a step towards single-embryo transfer. Hum Reprod 14,2345-2349.
41. Younis JS, Simon A and Laufer N (1996) Endometrial preparation - lessons from oocyte donation. Fertil Steril 66,873-884.
42. Zhou XL, Lei ZM and Rao CV (1999) Treatment of human endometrial gland epithelial cells with chorionic gonadotrophin/luteinizing hormone increases the expression of the cyclooxygenase-2 gene. J Clin Endocinol Metab 84,3364-3377.
43. Ziecik AJ, Derecka-Reszka K and Rzucidlo SJ (1992) Extragonadal gonadotropin receptors their distribution and function. J Physiol Pharmacol 34 (4 suppl 1),33-49.